𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Impact of “Off-Label” Utilization of Drug-Eluting Stents on Clinical Outcomes in Patients Undergoing Percutaneous Coronary Intervention

✍ Scribed by Probal Roy; Ashesh N. Buch; Aamir Javaid; Teruo Okabe; Vikram Raya; Tina L. Pinto Slottow; Daniel H. Steinberg; Kimberly Smith; Zhenyi Xue; Natalie Gevorkian; Lowell F. Satler; Kenneth M. Kent; William O. Suddath; Augusto D. Pichard; Joseph Lindsay; Ron Waksman

Book ID
113444377
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
288 KB
Volume
101
Category
Article
ISSN
0002-9149

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impact of overlapping drug-eluting stent
Impact of overlapping drug-eluting stents in patients undergoing percutaneous coronary intervention
✍ William W. Chu; Pramod K. Kuchulakanti; Rebecca Torguson; Betty Wang; Leonardo C 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 2 views

## Abstract Background: Sirolimus‐eluting stent (SES) implantation for the treatment of single coronary lesions is proven to be effective and durable. However, the safety and efficacy of overlapping SES for the treatment of long lesions have not been well established. Objectives: We conducted a ret

Impact of three or more sirolimus-elutin
Impact of three or more sirolimus-eluting stents versus paclitaxel-eluting stents on clinical outcomes in patients undergoing percutaneous coronary intervention
✍ William W. Chu; Pramod K. Kuchulakanti; Rebecca Torguson; Betty Wang; Leonardo C 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB 👁 2 views

## Abstract ## Objectives: The purpose of this study was to examine the clinical outcomes of patients who underwent stenting with ≥3 sirolimus‐eluting stents (SES) when compared with those treated with ≥3 paclitaxel‐eluting stents (PES). ## Background: Drug‐eluting stent (DES) implantation for s